# BioNexus Gene Lab Corp: Form 8-K, filed Nov 8, 2024

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2024-11-08
- Accepted by EDGAR: Nov 8, 2024, 22:25 ET
- Period: 2024-11-05
- Accession: 0001477932-24-006996
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224006996/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793224006996/

## Items reported

- Item 3.01: Delisting notice
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793224006996/bglc_8k.htm

Filed Nov 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001477932-24-006996. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.